ATE392152T1 - Coenzym q10 formulierungen - Google Patents

Coenzym q10 formulierungen

Info

Publication number
ATE392152T1
ATE392152T1 AT03702603T AT03702603T ATE392152T1 AT E392152 T1 ATE392152 T1 AT E392152T1 AT 03702603 T AT03702603 T AT 03702603T AT 03702603 T AT03702603 T AT 03702603T AT E392152 T1 ATE392152 T1 AT E392152T1
Authority
AT
Austria
Prior art keywords
coenzyme
formulations
matrix
droplets
gelatin
Prior art date
Application number
AT03702603T
Other languages
English (en)
Inventor
Chyi-Chen Chen
Bruno Leuenberger
Johann Ulm
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE392152T1 publication Critical patent/ATE392152T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Soft Magnetic Materials (AREA)
  • Lubricants (AREA)
AT03702603T 2002-02-14 2003-02-06 Coenzym q10 formulierungen ATE392152T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02003433 2002-02-14

Publications (1)

Publication Number Publication Date
ATE392152T1 true ATE392152T1 (de) 2008-05-15

Family

ID=27675622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702603T ATE392152T1 (de) 2002-02-14 2003-02-06 Coenzym q10 formulierungen

Country Status (9)

Country Link
US (1) US20050142123A1 (de)
EP (1) EP1476032B1 (de)
JP (1) JP2005517031A (de)
CN (1) CN1633245A (de)
AT (1) ATE392152T1 (de)
AU (1) AU2003205738A1 (de)
DE (1) DE60320380T2 (de)
ES (1) ES2302913T3 (de)
WO (1) WO2003068008A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718283B1 (de) 2004-01-22 2013-03-06 University of Miami Topische co-enzym q10 formulierungen und anwendungsverfahren
BRPI0611526A2 (pt) 2005-05-19 2009-11-24 Aqua Bio Technology Asa composição tópica contendo gelatina
US8951560B2 (en) * 2005-06-29 2015-02-10 Dsm Ip Assets B.V. Isoflavone nanoparticles and use thereof
EP1909763A2 (de) * 2005-07-28 2008-04-16 Isp Investments Inc. Benzochinone mit erhöhter bioverfügbarkeit
JP2009502969A (ja) 2005-07-28 2009-01-29 アイエスピー インヴェストメンツ インコーポレイテッド 非晶質エファビレンツ及びその製造
WO2007014566A2 (en) * 2005-08-04 2007-02-08 Basf Aktiengesellschaft Microcapsules and their use
JP2007161656A (ja) * 2005-12-15 2007-06-28 Arimino Kagaku Kk 毛髪化粧料
US20070184040A1 (en) * 2006-02-06 2007-08-09 Clouatre Dallas L Compositions for delivery of coenzyme Q10
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
WO2008080037A2 (en) 2006-12-21 2008-07-03 Isp Investments Inc. Carotenoids of enhanced bioavailability
US10189957B2 (en) 2007-01-26 2019-01-29 Isp Investments Llc Formulation process method to produce spray dried products
US8454945B2 (en) 2007-03-22 2013-06-04 Berg Pharma Llc Topical formulations having enhanced bioavailability
US20100092560A1 (en) * 2007-04-16 2010-04-15 Kaneka Corporation Reduced coenzyme q10-containing particulate composition and method for producing the same
CN101288641B (zh) * 2007-04-19 2012-07-11 浙江一新制药股份有限公司 辅酶q10水分散体及其制备方法
EP2173321B1 (de) * 2007-07-19 2024-12-18 DSM IP Assets B.V. Tablettierbare formulierung aus lipophilen medizinischen inhaltsstoffen
WO2009126764A1 (en) 2008-04-11 2009-10-15 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
KR101016741B1 (ko) 2008-07-16 2011-02-25 재단법인서울대학교산학협력재단 유비데카레논-함유 고체분산체의 제조방법
CN102482713B (zh) 2009-05-11 2017-06-30 博格有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂诊断肿瘤障碍的方法
ES2664793T3 (es) 2010-03-12 2018-04-23 Berg Llc Formulaciones intravenosas de coenzima Q10 (CoQ10) y métodos de uso de las mismas
CN102258474B (zh) * 2010-05-24 2012-10-10 富阳科兴生物化工有限公司 自微乳型辅酶q10粉状干乳的制备方法
CN102258473B (zh) * 2010-05-24 2013-03-13 富阳科兴生物化工有限公司 自微乳型辅酶q10粉状干乳及其应用
WO2012138765A1 (en) 2011-04-04 2012-10-11 Berg Pharma Llc Methods of treating central nervous system tumors
MX351781B (es) 2011-06-17 2017-10-30 Berg Llc Composiciones farmaceuticas inhalables.
JP6065585B2 (ja) * 2012-12-28 2017-01-25 ユーハ味覚糖株式会社 ガレート型カテキン含有化粧料
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
EP3041496B1 (de) 2013-09-04 2020-04-29 Berg LLC Verfahren zur behandlung von krebs mittels kontinuierlicher infusion von coenzym q10
JP6287123B2 (ja) * 2013-11-29 2018-03-07 ユーハ味覚糖株式会社 ユビキノール含有液状組成物
ES2938347T3 (es) * 2014-08-25 2023-04-10 Anatara Lifesciences Ltd Formulación antidiarreica que evita la resistencia antimicrobiana
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN110200910B (zh) * 2019-06-17 2022-04-19 北京中超海奇科技有限公司 一种辅酶q10透明水分散液的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951214A (ja) * 1982-09-16 1984-03-24 Taiho Yakuhin Kogyo Kk バイオアベイラビリテイの高い薬剤の製造方法
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
US5284674A (en) * 1992-05-11 1994-02-08 Fazio Susan C Powdered dairy creamer
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
DE69935946T2 (de) * 1998-06-24 2007-09-06 Dsm Ip Assets B.V. Vitaminpulver zur verwendung für getränke
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020103139A1 (en) * 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control

Also Published As

Publication number Publication date
CN1633245A (zh) 2005-06-29
AU2003205738A1 (en) 2003-09-04
ES2302913T3 (es) 2008-08-01
DE60320380D1 (de) 2008-05-29
EP1476032B1 (de) 2008-04-16
EP1476032A1 (de) 2004-11-17
JP2005517031A (ja) 2005-06-09
WO2003068008A1 (en) 2003-08-21
US20050142123A1 (en) 2005-06-30
DE60320380T2 (de) 2009-05-20

Similar Documents

Publication Publication Date Title
ATE392152T1 (de) Coenzym q10 formulierungen
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
BRPI0411001A (pt) produtos aril-heteroaromáticos, composições que os contêm e utilização
TW200734364A (en) Curable composition containing thiol compound
SE0301653D0 (sv) Novel compounds
BRPI0616071B8 (pt) métodos de revestir uma micropartícula cristalina pré-formada em suspensão com um agente ativo
EA200701246A1 (ru) Стабильные при комнатной температуре составы дронабинола
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
BRPI0504585A (pt) compreensão de contratos comerciais firmados legalmente por meio de modelos de gerenciamento de serviços
MXPA05007328A (es) Composiciones que contienen agentes antiacne y el uso de las mismas.
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
ATE399467T1 (de) Komprimierte harz-moderierte kaugummi
SV2007002422A (es) Derivados del (1,5-difenil-1h-pirazol-3-il)oxadiazol, su preparacion y su aplicacion en terapeutica.
BR0311347A (pt) Alcanóis bis-aromáticos
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
ATE452646T1 (de) Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat
BR0313751A (pt) Heterociclilpirimidinas substituìdas
BRPI0417205A (pt) composições farmacêuticas
DE60315711D1 (de) Aliphatische polyesterharz-zusammensetzung
EA200300917A1 (ru) Порошковый состав
DE602004004085D1 (de) Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel
TW200724152A (en) Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
NO20060743L (no) Nasal farmasoytisk sammensetning av piribedil

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties